Maccura Biotechnology completes registered capital reduction

Maccura Biotechnology Co., Ltd. (Maccura) announced the completion of its registered capital reduction and associated industrial and commercial alteration registration. The reduction stems from resolutions passed at the company's board, supervisory board, and extraordinary general meetings on June 11 and June 27, 2025. These resolutions included adjusting the use of shares held in the company's dedicated repurchase account and their cancellation, terminating the 2024 restricted stock incentive plan, repurchasing and cancelling first-class restricted shares, and cancelling second-class restricted shares.

The company's total share capital was initially reduced from 612,469,590 yuan to 608,624,624 yuan after the restricted stock repurchase and cancellation were finalized on August 28, 2025. A further reduction occurred when shares held in the dedicated repurchase account were cancelled on September 5, 2025, bringing the total share capital down to 604,666,624 yuan. Consequently, the company's registered capital has changed from 612,469,590 yuan to 604,666,624 yuan.

The total number of shares has also been adjusted from 612,469,590 ordinary yuan shares to 604,666,624 ordinary yuan shares. The company has since updated its business license with the revised information from the market supervision and administration bureau.